Department of Otolaryngology-Head and Neck Surgery, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY.
Department of Neurological Surgery, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY.
Int Forum Allergy Rhinol. 2019 Jun;9(6):674-680. doi: 10.1002/alr.22298. Epub 2019 Jan 18.
Respiratory epithelial adenomatoid hamartoma (REAH) is a recently classified histopathologic diagnosis often identified incidentally following endoscopic sinus surgery (ESS) for presumed chronic rhinosinusitis. Limited data exist defining preoperative imaging features and surgical outcomes. The purpose of this study is to examine characteristic imaging findings of REAH and postoperative olfactory and recurrence outcomes.
A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines on articles published from 1995 to present. PubMed, EMBASE, and Ovid MEDLINE databases were queried for studies pertinent to imaging findings of REAH and surgical outcomes. Quality of articles was assessed using the Methodological Index for Non-Randomized Studies (MINORS).
A total of 294 articles were identified, with 15 meeting inclusion criteria. Seven articles assessed both imaging findings and surgical outcomes. Three articles focused exclusively on imaging, whereas 5 examined surgical outcomes. Olfactory cleft (OC) widening greater than 10 mm on computed tomography (CT) was characteristic of REAH. A total of 441 patients with REAH were included; 221 patients (50.1%) had concurrent nasal polyposis, whereas 154 patients (34.9%) had isolated REAH. Surgical intervention ranged from simple excision to complete ESS. Sixty-five percent (65%) of patients reported improved olfaction; 4.1% of patients recurred with follow-up ranging from 4 months to 5 years.
A widened OC may suggest the presence of REAH. This disease process has been identified in patients with nasal polyposis or encountered as an isolated lesion. Targeted surgery may result in improved olfaction and a low likelihood of recurrence, though long-term prospective studies are necessary.
呼吸上皮腺瘤样错构瘤(REAH)是一种最近分类的组织病理学诊断,通常在因疑似慢性鼻-鼻窦炎而行内镜鼻窦手术(ESS)后偶然发现。目前,用于定义术前影像学特征和手术结果的资料有限。本研究旨在研究 REAH 的特征性影像学表现以及术后嗅觉和复发结果。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,对 1995 年至今发表的文章进行了系统综述。在 PubMed、EMBASE 和 Ovid MEDLINE 数据库中检索与 REAH 的影像学表现和手术结果相关的研究。使用非随机研究方法学指数(MINORS)评估文章的质量。
共确定了 294 篇文章,其中 15 篇符合纳入标准。有 7 篇文章评估了影像学发现和手术结果。有 3 篇文章专门研究影像学,5 篇研究手术结果。CT 上嗅裂增宽大于 10mm 是 REAH 的特征。共纳入 441 例 REAH 患者;221 例(50.1%)患者伴有鼻息肉,154 例(34.9%)患者为孤立性 REAH。手术干预范围从单纯切除到完全 ESS。65%的患者报告嗅觉改善;4.1%的患者在 4 个月至 5 年内复发。
嗅裂增宽可能提示存在 REAH。这种疾病过程在伴有鼻息肉的患者中或作为孤立病变被发现。有针对性的手术可能会改善嗅觉,且复发的可能性较低,但需要进行长期的前瞻性研究。